Page last updated: 2024-10-24

carmustine and Autoimmune Thrombocytopenia

carmustine has been researched along with Autoimmune Thrombocytopenia in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research Excerpts

ExcerptRelevanceReference
"We report a case series of childhood cancer survivors who developed an isolated thrombocytopenia in the presence of a normocellular bone marrow."1.33Immune thrombocytopenia following successful treatment of cancer in children. ( Barnes, C; Blanchette, V; Canning, P; Greenberg, M; Price, V, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Price, V1
Barnes, C1
Canning, P1
Blanchette, V1
Greenberg, M1

Other Studies

1 other study available for carmustine and Autoimmune Thrombocytopenia

ArticleYear
Immune thrombocytopenia following successful treatment of cancer in children.
    Pediatric blood & cancer, 2006, Volume: 46, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells; Carmustine; Child,

2006